MICC:NYSEThe Magnum Ice Cream Company N.V. Analysis
Data as of 2026-08-18 - not real-time
$19.09
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The Magnum Ice Cream Company N.V. is priced at $19.09 and its moving averages line up in bullish order, the shorter sitting above the longer. The last 30 days have gained 1.7%. Momentum indicators put RSI at 55.0 (neutral) with MACD reading bullish. Price has been bracketed by support at $17.39 and resistance at $20.10.
Valuation screens as overvalued, on a P/E of 56.1 with no clean sector comparison available. Revenue is growing at 4.2% on a 2.2% profit margin.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 27.6%, a beta of 0.43 and a maximum drawdown of 34.3%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, sell further out, at 4/10 long-term conviction.
Valuation screens as overvalued, on a P/E of 56.1 with no clean sector comparison available. Revenue is growing at 4.2% on a 2.2% profit margin.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 27.6%, a beta of 0.43 and a maximum drawdown of 34.3%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, sell further out, at 4/10 long-term conviction.
Top Market Events
Upslope Capital Management, an investment management company, released its second-quarter 2026 investor letter.Longleaf Partners, managed by Southeastern Asset Management, released its second-quarter 2026 investor letter for its...Magnum Ice Cream stock has delivered a 20.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 16.39
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 16.39
- MACD momentum is positive
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- P/E ratio of 56.1
- Elevated debt-to-equity of 343
- Price-to-book of 9.34
Key Metrics & Analysis
Financial Health
Revenue Growth4.20%
Profit Margin2.23%
P/E Ratio56.1
ROE9.64%
ROA7.26%
Debt/Equity342.69
P/B Ratio9.3
Op. Cash Flow$746.0M
Free Cash Flow$396.6M
Technical Analysis
TrendBullish
RSI55.0
Support$17.39
Resistance$20.10
MA 20$18.70
MA 50$18.19
MA 200$16.39
MACDBullish
VolumeDecreasing
Fear & Greed Index93.38
Valuation
Fair Value$4.60
Target Price$18.65
Upside/Downside-2.28%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.43
Volatility27.64%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.